Page 4 - IAV Digital Magazine #411

The only true FREE CLASSIFIEDS in the Antelope Valley... Where buyers and sellers meet!
Magic Mushrooms Could Help Treat Severe Depression
Psilocybin, the psyche- delic component of magic mushrooms, improved the symptoms of depression in a small- scale trial.
The trial, which was con- ducted on 12 people and has been published in The Lancet, found that the compound even worked on so called "treatment-resistant" depression. The research could provide the basis for radical new treatment for depression. "It is important that aca- demic research groups try to develop possible new treatments for depression as the phar- maceutical industry is pulling out of this field," said David Nutt, senior author of the research. "Our study has shown psilocybin is safe and fast acting so may, if administered carefully,
have value for these patients."
The research, con- ducted by a team at Imperial College London, monitored twelve participants (six men and six women aged between 30 and 64), all of whom knew they were receiving the compound. All participants had pre- viously taken at least two courses of antidepressants, to which they did not respond, and eleven had undergone psy- chotherapy.
Eligibility for the tri- als meant that par- ticipants who had attempted suicide or those who had experi- enced psychosis were screened out.
The group was given two doses of a psilocy- bin capsule seven days apart. Patients showed a "decrease in symptoms
of depression" for at least three weeks after the dosage was adminis- tered, with seven partici- pants continuing to show
a positive response up to "three months" after the treat- ment.
Participants reported feeling "relaxed", as well as having a "most- ly pleasant and sometimes beauti- ful" experience.
Though the results are positive, the sample size was small and further research will need to be done into the effects of the compound. Researchers also warned that drugs should not be taken without
supervision. "Psychedelic drugs have potent psychological effects and are only given in our research
when appropriate safe- guards are in place, such as careful screen- ing and professional therapeutic support," said lead author Robin Carhart-Harris. "I would- n't want members of the public thinking they can treat their own depres- sions by picking their own magic mushrooms. That kind of approach could be risky."
Other trials have found positive psychological effects of recreational drugs. In a studypub- lished in Nature in May of this year, a chemical byproduct of ketamine was found to have anti- depressant effect on mice. And in April, Imperial College released images that they say showed how the brain becomes "uni- fied" under the influence of LSD.
4
661-266-4-ADS
ANTELOPE VALLEY FREE CLASSIFIEDS ;